These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39155523)

  • 1. Progress in the field of animal models of antiphospholipid syndrome.
    Gao X; Ma D; Mi L; Zhao J; An Q; Guo Z; Yang B; Zhang L; Xu K
    Autoimmunity; 2024 Dec; 57(1):2391350. PubMed ID: 39155523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R; Qin L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS dysfunction in the antiphospholipid syndrome.
    Katzav A; Chapman J; Shoenfeld Y
    Lupus; 2003; 12(12):903-7. PubMed ID: 14714909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does seronegative obstetric APS exist? "pro" and "cons".
    Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
    Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
    Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H
    Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.
    Devreese KMJ
    Int J Lab Hematol; 2024 May; 46 Suppl 1():34-42. PubMed ID: 38584293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome in pregnancy--animal models and clinical implications.
    Shoenfeld Y; Sherer Y; Blank M
    Scand J Rheumatol Suppl; 1998; 107():33-6. PubMed ID: 9759129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome.
    Müller-Calleja N; Ruf W; Lackner KJ
    Crit Rev Clin Lab Sci; 2024 Aug; 61(5):370-387. PubMed ID: 38293818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of antiphospholipid antibody-associated pregnancy complications.
    Abrahams VM
    Thromb Res; 2009 Nov; 124(5):521-5. PubMed ID: 19665761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
    Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
    Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.
    Oku K; Amengual O; Yasuda S; Atsumi T
    Curr Rheumatol Rep; 2017 Aug; 19(8):51. PubMed ID: 28741233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome.
    Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I
    Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top 10 clinical research developments in antiphospholipid syndrome.
    Barbhaiya M; Erkan D
    Curr Rheumatol Rep; 2013 Oct; 15(10):367. PubMed ID: 24014256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.